glp-1 iih Infographic: Landmark trials in Neuro-Ophthalmology—results of the phase II Idiopathic Intracranial Hypertension Pressure Trial GLP-1 Receptor Agonists in Idiopathic

Whether you're considering compounded semaglutide, compounded tirzepatide, or simply trying to understand your options, this is the resource we wish every patient had access to

Dabelea, D

Editado por: Silvia Pellitero-Rodrguez - University Hospital Germans Trias i Pujol Badalona Federico Vzquez Sanmiguel - University Hospital Germans Trias i Pujol Badalona ltima actualizacin : Octubre 2025 Los frmacos con accin sobre el receptor del pptido similar al glucagn tipo 1 (GLP-1) son efectivos en el tratamiento de enfermedades metablicas asociadas a la obesidad, como la apnea obstructiva del sueo (AOS), la enfermedad heptica metablica (EHMET) y la enfermedad renal crnica (ERC)

Small 16 , 1902242 (2020)

Background technique [0002] Semaglutide, a long-acting GLP-1 analog developed by Nove Nordisk for subcutaneous injection once a week, was approved by the US FDA on December 5, 2017